QMD-31725-72554
3 vaccinations
5 coded responses
21 check-ins
5 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 05-11
- ZIP prefix
- 606 / IL
- Registered
- 2021-11-14
- Relationship
- Child or adolescent in my care
- Guardian
- Z2A-16991-05557
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-11-11
Dose 1 — Pfizer-BioNTech
-
2021-11-14
Registered in v-safe
-
2021-11-14
Survey response — days 1–6 daily, dose 1, dependentMedDRA: Oropharyngeal pain — Feeling: Poor · Site: Pain · Fever · Chills, Headache, Fatigue or tiredness · Be unable to work or attend schoolFree text: Sore throat. Started the night of the vaccineMedDRA releases: 2024-11 · check-in free text available
-
2021-11-15
Survey response — days 1–6 daily, dose 1, dependentMedDRA: Cough, Oropharyngeal pain — Feeling: Fair · Site: Pain · Fever · Chills, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend schoolFree text: Cough and sore throatMedDRA releases: 2024-11 · check-in free text available
-
2021-11-16
Survey response — days 1–6 daily, dose 1, dependentMedDRA: Cough, Oropharyngeal pain — Feeling: Poor · Fever · Chills, Fatigue or tiredness, Abdominal pain · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Cough, mild sore throatMedDRA releases: 2024-11 · check-in free text available
-
2021-11-17
Survey response — days 1–6 daily, dose 1, dependentMedDRA: Office visit — Feeling: Poor · Fever · Fatigue or tiredness, Nausea · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Normal Dr. AppointmentMedDRA releases: 2024-11 · check-in free text available
-
2021-11-17
Report sent to call center — days 1–6 daily, dose 1, dependentBe unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · 1 call case(s)
-
2021-11-18
Health check-in — day 7, dose 1, dependentFeeling: Fair · Fever · Chills, Fatigue or tiredness, Nausea · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
-
2021-11-22
Call successfulCompleted over the phone
- 2021-11-25
-
2021-12-02
Dose 2 — Pfizer-BioNTech
-
2021-12-04
Health check-in — days 1–6 daily, dose 2, dependentFeeling: Good · Site: Pain · Muscle or body achesAdult check-in
-
2021-12-05
Health check-in — days 1–6 daily, dose 2, dependentFeeling: Good · Site: Pain, Itching · NoneAdult check-in
-
2021-12-06
Health check-in — days 1–6 daily, dose 2, dependentFeeling: Good · Site: Pain, Itching · NoneAdult check-in
- 2021-12-09
- 2021-12-16
- 2021-12-23
- 2021-12-30
- 2022-01-08
- 2022-01-13
- 2022-03-03
-
2022-09-29
Dose 3 — Pfizer-BioNTechCo-administered: Flu
-
2022-10-13
Survey response — day 14, dose 3, dependentMedDRA: Fatigue, Lymphadenopathy, Office visit — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professionalFree text: Symptoms: For almost a full week after being vaccinated my daughter suffered from extreme exhaustion. Additionally she had a swollen lymph node in her chest that was momentarily a major cause of concern. · Healthcare visit (other): Multiple appointments with her primary care teamMedDRA releases: 2024-11 · check-in free text available
-
2022-10-13
Report sent to call center — day 14, dose 3, dependentBe unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr1 call case(s)
-
2022-10-14
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
- 2022-10-20
- 2022-11-03
- 2022-11-10
- 2022-12-29
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-11-11 | Pfizer-BioNTech | No |
| 2 | 2021-12-02 | Pfizer-BioNTech | No |
| 3 | 2022-09-29 | Pfizer-BioNTech | Flu |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-11-17 | Successful 2021-11-22 |
Completed over the phone |
| 2022-10-13 | Successful 2022-10-14 |
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill |
Free text
Release 10 — days 1–6 daily, dose 1, dependent
Systemic reaction (other): Sore throat. Started the night of the vaccine
Systemic reaction (other): Cough and sore throat
Systemic reaction (other): Cough, mild sore throat
Healthcare visit (other): Normal Dr. Appointment
Release 12 — day 14, dose 3, dependent
Symptoms: For almost a full week after being vaccinated my daughter suffered from extreme exhaustion. Additionally she had a swollen lymph node in her chest that was momentarily a major cause of concern.
Healthcare visit (other): Multiple appointments with her primary care team
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Lymphadenopathy | · | · | ✓ |
| SRO | Cough | · | · | ✓ |
| SRO | Oropharyngeal pain | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release